Pharmaceuticals, Biotechnology and Life Sciences
CHENGDU, China, Jan. 21, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing…
Phase 2 trial to evaluate reduction in heavy drinking as measured by a change in the World Health Organization drinking…
SANTA MONICA, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) — Correction: Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty…
Robust financial strength positions Company to deploy Impact CapitalANN ARBOR, Mich., Jan. 20, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories,…
NEW HAVEN, Conn., Jan. 20, 2022 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a biopharmaceutical company…
— Single-cell proteomics can elucidate kinase activity in prostate cancer models — — Kinase activity in bone metastases and epithelial…
Session will include a discussion of the treatment landscape for Mantle Cell Lymphoma, including potential role of Zilovertamab, Oncternal’s ROR1…
The TRials with EblasaKimab in Atopic Dermatitis (TREK-AD) study will evaluate the efficacy and safety of ASLAN004, now known as…
– FDA lifts partial clinical hold following agreement on mitigation strategy for differentiation syndrome – – KOMET-001 study to resume…
Daix (France), Long Island City (New York, United States), January 20, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a…